Ceftriaxone for meningitis, due to Escherichia coli, which developed during tobramycin therapy. | N Z Med J;97(760): 500, 1984 Jul 25. | MEDLINE

Main content 1 Search 2 Footer 3

+A A -A High contrast

VHL Regional Portal

Information and Knowledge for Health

Subject descriptor lookup Advanced Search EVID@Easy

Ceftriaxone for meningitis, due to Escherichia coli, which developed during tobramycin therapy.

Shaw, D W; Ali, R M; Beeching, N J; Lang, S D.

N Z Med J ; 97(760): 500, 1984 Jul 25.

Article in En | MEDLINE | ID: mdl-6089061

Subject(s)

Cefotaxime/analogs & derivatives; Escherichia coli Infections; Meningitis/etiology; Tobramycin/adverse effects; Cefotaxime/therapeutic use; Ceftriaxone; Drug Resistance, Microbial; Escherichia coli Infections/drug therapy; Female; Humans; Meningitis/drug therapy; Middle Aged

Search on Google

Collection: 01-internacional Database: MEDLINE Main subject: Tobramycin / Cefotaxime / Escherichia coli Infections / Meningitis Limits: Female / Humans / Middle aged Language: En Journal: N Z Med J Year: 1984 Document type: Article Country of publication: New Zealand

Search on Google

Collection: 01-internacional Database: MEDLINE Main subject: Tobramycin / Cefotaxime / Escherichia coli Infections / Meningitis Limits: Female / Humans / Middle aged Language: En Journal: N Z Med J Year: 1984 Document type: Article Country of publication: New Zealand